Emtora Biosciences Alternatives & Competitors
12 companies similar to Emtora Biosciences — Commercializing eRapa™, a novel, targeted formulation of rapamycin, for the prev...
Companies similar to Emtora Biosciences
Cancer Prevention Pharmaceuticals, Inc
Developing therapeutics to reduce the risk and recurrence of cancer and other diseases.
Biodexa Pharmaceuticals PLC
Advancing Medicines for a Brighter Future
Cardiff, United Kingdom
Calico Life Sciences
We're tackling aging, one of life's greatest mysteries
South San Francisco, Unit...
Senex Biotechnology. Inc.
Preventing Adaptive Drug Resistance and Cancer Metastasis
Rival Readout
Competing with Emtora Biosciences? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Cinclus Pharma
Developing effective treatment for gastric acid related diseases.
Stockholm, Sweden
GLG Pharma
Why Show the GSK Compound? Because the cancer cells become resistant. How? By STAT3! GLG's...
Jupiter, United States
Alzprotect SAS
Therapeutic Solutions for Neurodegeneration
Loos, France
Samsara Therapeutics
Treating Neurodegenerative Disease by Restoring Autophagy
Oxford, United Kingdom
Madison Vaccines
Developing innovative vaccines for prostate cancer patients and a test to determine their...
Flame Biosciences
A clinical-stage pioneer focused on discovering, developing, and commercializing groundbre...
Veloxis Pharmaceuticals, Inc.
Let's transform transplant medicine. Together
Cary, United States
About Emtora Biosciences
Emtora Biosciences is a biotechnology startup based in the United States specializing in developing a targeted formulation of rapamycin, known as eRapa™, for the prevention and potential recurrence of cancer. The company was founded in 2012 and has recently received a significant boost with a $16.90M grant investment f...
Emerging Biotech, Cancer Prevention, Rapamycin, ERapa, Clinical Trials, Pharmaceutical Research, Prostate Cancer, Age-related Diseases, Life Science Company, Immunosuppressant, Healthspan, Lifespan Extension, Scientific Breakthroughs, Precision Medicine, Drug Development
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Emtora Biosciences: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Emtora Biosciences on 14 Sep 2024. The 12 companies listed here were last checked between 25 Jul 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
